Is MEDOF or EQR a better dividend investment in 2026?

MEDOF currently yields 4.00% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: EQR offers higher current income.

What is the dividend yield difference between MEDOF and EQR?

MEDOF has a forward dividend yield of 4.00% ($2.00/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 1.87 percentage points.

Home › Compare › MEDOF vs EQR

MEDOF vs EQR: Dividend Comparison 2026

MEDOF yields 4.00% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 EQR wins by $21.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDOF

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$517.11

Full MEDOF calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — MEDOF vs EQR

📍 EQR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDOF	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDOF + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDOF pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$439.54/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, EQR beats the other by $4,214.72/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + EQR for your $10,000?

MEDOF: 50%EQR: 50%

100% EQR50/50100% MEDOF

Portfolio after 10yr

$36.9K

Annual income

$2,996.36/yr

Blended yield

8.13%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

MEDOF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

5/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys

EQR buys

No recent congressional trades found for MEDOF or EQR in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDOFEQR

Forward yield	4.00%	5.87% ✓
Annual dividend / share	$2.00	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.8% ✓
Portfolio after 10y	$25.9K	$47.8K ✓
Annual income after 10y	$517.11	$5,475.61 ✓
Total dividends collected	$4.6K	$23.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT
Analyst consensus	Buy	Hold

Year-by-year: MEDOF vs EQR ($10,000, DRIP)

Year	MEDOF Portfolio	MEDOF Income/yr	EQR Portfolio	EQR Income/yr	Gap
1← crossover	$11,100	$400.00	$11,380	$679.82	$280.00 → EQR
2	$12,292	$414.95	$13,014	$837.25	$722.00 → EQR
3	$13,582	$429.45	$14,961	$1,036.20	$1.4K → EQR
4	$14,976	$443.47	$17,297	$1,289.22	$2.3K → EQR
5	$16,481	$457.01	$20,121	$1,613.15	$3.6K → EQR
6	$18,105	$470.04	$23,561	$2,030.84	$5.5K → EQR
7	$19,855	$482.57	$27,783	$2,573.54	$7.9K → EQR
8	$21,739	$494.59	$33,013	$3,284.39	$11.3K → EQR
9	$23,767	$506.10	$39,547	$4,223.51	$15.8K → EQR
10	$25,948	$517.11	$47,791	$5,475.61	$21.8K → EQR

MEDOF vs EQR: Complete Analysis 2026

MEDOF — Stock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this MEDOF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHD MEDOF vs JEPI MEDOF vs O MEDOF vs KO MEDOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.